Overview
Rhabdomyolysis
Quick Reference
Critical Alerts
- AKI occurs in 15-50%: Aggressive IV fluids are key to prevention
- Hyperkalemia can be fatal: Monitor potassium closely; treat aggressively
- CK >5000 is high risk for AKI: Threshold for aggressive hydration
- Compartment syndrome may coexist: Check compartments in trauma
- Target urine output 200-300 mL/hr: High-volume fluid resuscitation
- Avoid nephrotoxins: NSAIDs, contrast, aminoglycosides
Key Diagnostics
| Test | Finding | Significance |
|---|---|---|
| CK (Creatine Kinase) | >1000 U/L (often >0,000) | Defines rhabdomyolysis |
| Potassium | Elevated | Life-threatening arrhythmia risk |
| Creatinine | Elevated | Indicates AKI |
| Urinalysis | Positive blood, no RBCs | Myoglobinuria |
| Calcium | Low (early) or high (late) | Calcium sequestration then release |
| Phosphate | Elevated | Released from muscle cells |
Emergency Treatments
| Intervention | Details | Goal |
|---|---|---|
| IV fluids | NS or LR 1-2 L/hr initially | UO 200-300 mL/hr |
| Hyperkalemia | Calcium gluconate, insulin/glucose, albuterol | Cardioprotection + shift |
| Metabolic acidosis | Bicarbonate (controversial) | pH >.2 |
| Dialysis | If refractory hyperkalemia or severe AKI | RRT |
Definition
Overview
Rhabdomyolysis is the breakdown of skeletal muscle fibers with release of intracellular contents (myoglobin, creatine kinase, potassium, phosphate) into the bloodstream. It ranges from asymptomatic CK elevation to life-threatening acute kidney injury (AKI) and fatal hyperkalemia.
Classification
By Severity:
| Category | CK Level | Risk |
|---|---|---|
| Mild | <5,000 U/L | Low AKI risk |
| Moderate | 5,000-15,000 U/L | Moderate AKI risk |
| Severe | >5,000 U/L | High AKI risk |
| Massive | >00,000 U/L | Very high risk |
By Cause:
| Type | Examples |
|---|---|
| Traumatic | Crush injury, compartment syndrome, surgery |
| Exertional | Exercise, seizures, heat stroke |
| Non-traumatic/non-exertional | Drugs, infections, metabolic |
Epidemiology
- Incidence: 26,000+ hospitalizations/year in US
- AKI incidence: 15-50% of rhabdomyolysis patients
- Mortality: 5% overall; higher with AKI and dialysis
- Most common causes: Trauma (30%), drugs/toxins (30%), immobilization (15%)
Etiology
Common Causes:
| Category | Causes |
|---|---|
| Trauma/Compression | Crush injury, prolonged immobility, coma, restraints |
| Exertional | Intense exercise, marathon, military training, seizures |
| Drugs/Toxins | Statins, cocaine, amphetamines, alcohol, heroin |
| Infections | Viral (influenza, COVID), bacterial (Legionella, Strep) |
| Metabolic | Hypokalemia, hypophosphatemia, DKA, hypothyroidism |
| Hyperthermia | Heat stroke, malignant hyperthermia, NMS |
| Ischemia | Compartment syndrome, arterial occlusion |
| Inflammatory | Dermatomyositis, polymyositis |
| Genetic | McArdle disease, malignant hyperthermia susceptibility |
Drug-Induced Rhabdomyolysis:
| Category | Agents |
|---|---|
| Statins | Especially with fibrates or CYP3A4 inhibitors |
| Illicit drugs | Cocaine, amphetamines, MDMA, heroin |
| Alcohol | Binge drinking, immobility |
| Antipsychotics | NMS |
| Sedatives | Immobilization |
| Colchicine | Toxicity |
| Propofol | Propofol infusion syndrome |
Pathophysiology
Mechanism of Muscle Injury
- ATP depletion: Ischemia, exertion, or drugs → decreased ATP
- Pump failure: Na+/K+-ATPase and Ca2+-ATPase fail
- Intracellular calcium rises: Activates proteases and lipases
- Myocyte necrosis: Cell membrane ruptures
- Contents released: CK, myoglobin, K+, phosphate, uric acid
Mechanism of Acute Kidney Injury
| Mechanism | Pathophysiology |
|---|---|
| Renal vasoconstriction | Myoglobin scavenges NO |
| Tubular obstruction | Myoglobin precipitates in acidic urine |
| Direct tubular toxicity | Free iron from myoglobin generates ROS |
| Hypovolemia | Third-spacing into injured muscle |
Factors Increasing AKI Risk:
- Volume depletion
- Acidic urine (pH <5.6)
- CK >15,000 U/L
- Pre-existing renal impairment
- Sepsis
- DIC
Electrolyte Disturbances
| Electrolyte | Early Phase | Mechanism |
|---|---|---|
| Potassium | ↑ Hyperkalemia | Release from cells |
| Phosphate | ↑ Hyperphosphatemia | Release from cells |
| Calcium | ↓ Hypocalcemia | Calcium deposits in damaged muscle |
| Uric acid | ↑ Hyperuricemia | Purine breakdown |
Late Phase:
- Hypercalcemia (as calcium remobilizes from muscle)
Clinical Presentation
Classic Triad (Present in <10%)
- Myalgia: Muscle pain and tenderness
- Weakness: Affected muscle groups
- Dark urine: "Cola-colored" or "tea-colored" (myoglobinuria)
Symptoms
Musculoskeletal:
Systemic:
Urinary:
History
Key Questions:
Physical Examination
Vital Signs:
Musculoskeletal:
| Finding | Significance |
|---|---|
| Muscle tenderness | Affected muscle groups |
| Muscle swelling | Edema, possible compartment syndrome |
| Firmness | Compartment syndrome |
| Weakness | May be profound |
Compartment Syndrome Assessment:
Other:
Muscle pain (50% of cases)
Common presentation.
Muscle weakness
Common presentation.
Muscle swelling
Common presentation.
Tenderness to palpation
Common presentation.
Red Flags
Life-Threatening Complications
| Finding | Concern | Action |
|---|---|---|
| K+ >.5 mEq/L or ECG changes | Cardiac arrhythmia risk | Calcium, insulin/glucose, dialysis |
| Oliguria/anuria | Acute kidney injury | Aggressive fluids, nephrology |
| Metabolic acidosis (pH <7.2) | Severe rhabdomyolysis | Bicarbonate, dialysis |
| Compartment syndrome | Limb-threatening | Emergent fasciotomy |
| CK >00,000 U/L | Very high AKI risk | ICU, aggressive management |
| DIC | Multi-organ failure | Supportive care |
| Cardiac arrest (from hyperkalemia) | Fatal | ACLS, dialysis |
High-Risk Features
- CK >15,000 U/L
- Pre-existing CKD
- Diabetes
- Sepsis
- Delayed presentation
- Initial creatinine elevation
Differential Diagnosis
Other Causes of Elevated CK
| Diagnosis | Features |
|---|---|
| Acute MI | Chest pain, ECG changes, troponin > CK elevation |
| Myocarditis | Chest pain, ECG changes, cardiac biomarkers |
| Myositis (inflammatory) | Chronic, proximal weakness, dermatomyositis rash |
| Hypothyroidism | Fatigue, modest CK elevation, TFTs abnormal |
| Muscular dystrophy | Chronic, family history, characteristic pattern |
| Statin myopathy (without rhabdo) | Myalgias, mild CK elevation |
Other Causes of Dark Urine
| Diagnosis | Features |
|---|---|
| Hemoglobinuria | Hemolysis, positive hemolysis markers |
| Hematuria | RBCs on microscopy |
| Porphyria | Neuropsychiatric symptoms, abdominal pain |
| Bile pigments | Elevated bilirubin, liver disease |
Diagnostic Approach
Laboratory Studies
| Test | Purpose | Expected Findings |
|---|---|---|
| CK (Creatine Kinase) | Diagnostic | >5× ULN (often >0,000) |
| BMP | Renal function, K+ | Elevated Cr, K+, phosphate; low Ca2+ |
| Urinalysis | Myoglobinuria | Blood positive, no RBCs on microscopy |
| Myoglobin | Confirmation | Elevated (less practical than CK) |
| CBC | Assess for sepsis, DIC | WBC elevated, low platelets if DIC |
| Coagulation | DIC screen | PT/PTT elevated if DIC |
| Liver enzymes | Baseline | May be mildly elevated |
| Lactate | Perfusion | Elevated if severe |
| ABG/VBG | Acidosis | Metabolic acidosis |
| Uric acid | Tumor lysis, rhabdo | Elevated |
Urinalysis Interpretation
| Parameter | Finding |
|---|---|
| Blood (dipstick) | Positive |
| RBCs (microscopy) | Absent or few |
| Color | Dark brown ("cola") |
Positive blood without RBCs = Myoglobinuria (or hemoglobinuria)
ECG
- Monitor for hyperkalemia changes:
- Peaked T waves
- Prolonged PR
- Wide QRS
- Sine wave (pre-arrest)
Imaging
- CK/labs confirm diagnosis
- Imaging for underlying cause or complications:
- CT/MRI: Muscle necrosis, abscess
- Compartment pressure: If clinical concern
- Venous Doppler: DVT (from immobility)
Treatment
Principles of Management
- Aggressive IV fluids: Prevent AKI (most important)
- Treat hyperkalemia: Life-threatening
- Monitor and correct electrolytes: Calcium, phosphate
- Treat underlying cause: Stop offending drug, treat infection
- Avoid nephrotoxins: NSAIDs, contrast, aminoglycosides
- Dialysis if refractory: Severe AKI or hyperkalemia
IV Fluid Resuscitation
Target: Urine output 200-300 mL/hr (3 mL/kg/hr)
| Phase | Fluid | Rate |
|---|---|---|
| Initial resuscitation | NS or LR | 1-2 L/hr first few hours |
| Maintenance | NS or LR | Titrate to goal UOP |
| When stabilized | Taper as CK falls | Continue until CK <5000 and stable |
Choice of Fluid:
- Normal saline: Most commonly used
- Lactated Ringer's: Contains small potassium; some avoid in hyperkalemia
- Bicarbonate: Controversial; may alkalize urine but not proven beneficial
Urine Alkalization (Controversial):
- Theoretical benefit: Myoglobin less toxic at pH >6.5
- Regimen: Add bicarbonate to IV fluids
- Evidence: Limited; may worsen hypocalcemia
- NOT routinely recommended by current guidelines
Hyperkalemia Management
| Intervention | Dose | Mechanism |
|---|---|---|
| Calcium gluconate | 10 mL of 10% IV | Cardioprotection (no K+ decrease) |
| Insulin + Glucose | 10 units regular + 25g D50 | Shift K+ intracellularly |
| Albuterol | 10-20 mg nebulized | Shift K+ intracellularly |
| Sodium bicarbonate | 50-100 mEq IV | Shift K+ (if acidotic) |
| Kayexalate | 15-30g PO or enema | Elimination (slow) |
| Dialysis | If refractory or severe | Definitive elimination |
Electrolyte Management
Hypocalcemia:
- Treat only if symptomatic (tetany, seizures, arrhythmia)
- Aggressive calcium replacement may worsen deposition
- Calcium rebinds calcium deposited in muscle during recovery
Hyperphosphatemia:
- Usually resolves with fluids
- Phosphate binders if severe
Acidosis:
- Bicarbonate if pH <7.1-7.2
- Usually improves with fluids
Dialysis Indications
| Indication |
|---|
| Refractory hyperkalemia |
| Refractory metabolic acidosis |
| Severe oliguria/anuria |
| Volume overload |
| Uremic symptoms |
Compartment Syndrome
- Emergent surgical fasciotomy
- Do not wait for CK or other labs
- Clinical diagnosis
Specific Therapies for Underlying Cause
| Cause | Treatment |
|---|---|
| Statins | Discontinue; avoid reintroduction |
| Illicit drugs | Supportive care, benzodiazepines for agitation |
| NMS | Stop antipsychotic, dantrolene, cooling |
| Malignant hyperthermia | Dantrolene, cooling, supportive |
| Heat stroke | Aggressive cooling, fluids |
| Seizures | Terminate seizure |
| Infection | Appropriate antibiotics/antivirals |
Disposition
ICU Admission Criteria
- CK >15,000-20,000 U/L
- Acute kidney injury
- Significant hyperkalemia
- Hemodynamic instability
- Need for dialysis
- Underlying critical illness
Floor Admission
- Moderate CK elevation (5,000-15,000)
- Stable renal function
- No significant electrolyte derangement
Discharge Criteria
- CK trending down
- Creatinine stable or improving
- Adequate oral intake
- No electrolyte abnormalities
- Cause addressed
Follow-Up
| Situation | Follow-Up |
|---|---|
| Mild/resolving | PCP in 1-2 weeks; repeat CK and renal function |
| Post-AKI | Nephrology follow-up |
| Recurrent episodes | Consider genetic evaluation for metabolic myopathies |
| Statin-related | Cardiology for alternative lipid management |
Patient Education
Condition Explanation
- "Your muscle cells have broken down, releasing their contents into your blood."
- "This can affect your kidneys and cause dangerous changes in your blood salt levels."
- "We need to give you a lot of fluids to flush your kidneys and keep them working."
Prevention
- Gradual increase in exercise intensity
- Adequate hydration during exercise
- Avoid extreme exertion in heat
- Know signs of overexertion
Medication Awareness
- Report muscle pain on statins immediately
- Avoid combining statins with certain medications
Warning Signs for Return
- Return of muscle pain or weakness
- Dark urine
- Decreased urine output
- Swelling of limbs
- Palpitations or lightheadedness
Special Populations
Exertional Rhabdomyolysis
- More common in unconditioned individuals
- Seen with novel exercise ("weekend warriors")
- NSAID use increases AKI risk
- Prevention: Gradual training, hydration
Statin-Induced
- Risk factors: High-dose, CYP3A4 inhibitors, hypothyroidism
- Discontinue statin; usually resolves
- Rechallenge with different statin after resolution (with caution)
Crush Injury / Earthquake Victims
- "Crush syndrome": Massive rhabdomyolysis + AKI + hyperkalemia
- Start fluids before extrication if possible
- Prepare for dialysis
- Consider tourniquet to prevent reperfusion flush
Pediatric
- Viral myositis is common cause
- Genetic metabolic myopathies
- Generally good prognosis
Elderly
- Prolonged immobility is common cause
- Higher AKI risk
- More comorbidities
Quality Metrics
Performance Indicators
| Metric | Target | Rationale |
|---|---|---|
| IV fluids initiated within 1 hour | 100% | Prevents AKI |
| Potassium monitored q4-6h | 100% | Detect hyperkalemia |
| Urine output documented | 100% | Guide fluid therapy |
| Nephrotoxins avoided | 100% | Prevent additional injury |
| CK trending | 100% | Monitor response |
| Nephrology consult for AKI | 100% | Specialty input |
Documentation Requirements
- Suspected or confirmed cause
- Initial CK and peak CK
- Urine output and fluid administration
- Potassium trend and treatment
- Creatinine trend
- Disposition plan
Key Clinical Pearls
Diagnostic Pearls
- CK is very sensitive: Can be elevated before symptoms
- Dipstick positive blood without RBCs = myoglobinuria: Classic finding
- Check for compartment syndrome in trauma: Pain out of proportion
- CK >5000 = high risk for AKI: Threshold for aggressive management
- Ask about drugs and exercise: Most common modifiable causes
- Serum myoglobin is less useful: Clears before CK
Treatment Pearls
- Fluids are the mainstay: Target UO 200-300 mL/hr
- Don't wait for AKI to start fluids: Prevention is key
- Bicarbonate not routinely recommended: May worsen hypocalcemia
- Don't give calcium for asymptomatic hypocalcemia: May deposit in muscle
- Treat hyperkalemia aggressively: It can kill quickly
- Stop offending drugs: Statins, cocaine, etc.
Disposition Pearls
- ICU for CK >15,000-20,000 or AKI: Close monitoring needed
- Monitor CK until trending down: May continue to rise for 1-3 days
- Recurrent rhabdomyolysis: Consider metabolic myopathy workup
- Statin rechallenge possible: With different agent, low dose, monitoring
References
- Bosch X, et al. Rhabdomyolysis and Acute Kidney Injury. N Engl J Med. 2009;361(1):62-72.
- Chavez LO, et al. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016;20(1):135.
- Giannoglou GD, et al. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med. 2007;18(2):90-100.
- Brown CV, et al. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma. 2004;56(6):1191-1196.
- Zimmerman JL, Shen MC. Rhabdomyolysis. Chest. 2013;144(3):1058-1065.
- Torres PA, et al. Rhabdomyolysis: Pathogenesis, Diagnosis, and Treatment. Ochsner J. 2015;15(1):58-69.
- KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):1-138.
- UpToDate. Clinical features and diagnosis of rhabdomyolysis. 2024.